Skip to main content
Equibles
HIND logo

HIND · Vyome Holdings, Inc

Track HIND — free

Use HIND with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$2.18 +0.01 (+0.27%)
Rebalance outlook locked
Market Cap
$15.23M
Shares
7.02M

HIND metrics

60 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$2.17
Market cap
$15.23M

Price action

19 metrics
Price change (1W)
-2.7%
Price change (30D)
+0.2%
Price change (3M)
-5.7%
Price change (6M)
-30.7%
Price change (YTD)
-36.9%
Price change (1Y)
-76.4%
Trailing year
Price change (5Y)
—
52-week high
$8.56
52-week low
$1.89
Change from 52-week high
-74.6%
Change from 52-week low
+14.8%
Annualized volatility
81.1%
Beta
1.2
RSI (14D)
47.4
Price vs SMA 50
-0.2%
Price vs SMA 200
-20.5%
Avg volume (3M)
14,274
Relative volume
0.4
Average dollar volume
$31,301

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
7.02M

Valuation

12 metrics
P / E (TTM)
0.0
Trailing earnings · reciprocal yield 71,722.6%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
117.4×
reciprocal yield 0.9%
P / book
2.1
reciprocal yield 48.0%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-74.2%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-06-03

Profitability

9 metrics
Gross margin
52.7%
Operating margin
-9,190.1%
Trailing 12 months
Net margin
-8,716.7%
Gross profit (TTM)
$68,420
Operating profit (TTM)
−$11.92M
Net income (TTM)
−$11.31M
Trailing 12 months
Diluted EPS (TTM)
$1,556.38
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-27,803,142.27

Growth

11 metrics
Revenue growth YoY
-46.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$129,725
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+1,733,130.8%
Year over year · more shares
Revenue CAGR (3Y)
-69.5%
Revenue CAGR (5Y)
-51.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-154.7%
Return on assets
-123.2%
Debt / equity
—
Current ratio
4.4
EBITDA (TTM)
−$11.91M
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
-285.8
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
—
Total assets
$9.18M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$5.58M
Capital expenditures (TTM)
$43,000
R&D (TTM)
$1.59M
SG&A (TTM)
$2.68M
Stock compensation (TTM)
$566,875
R&D / revenue
1,226.5%
Stock compensation / revenue
437.0%

Ownership (13F)

3 metrics
13F filers
12
13F filer change QoQ
+3
Institutional ownership
2.0%

Short interest

3 metrics
Short interest
0.3%
Latest settlement · 3.0 days to cover
Days to cover
3.0d
Short-squeeze score
40 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1427570 CUSIP 92943X104 13F (30d) 12 filings 12 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)